Cell sources for bone regeneration: The good, the bad, and the ugly (But Promising)

Tissue Engineering - Part B: Reviews

Volumn 17, Issue 6, 2011, Pages 423-430

  Robey, Pamela Gehron ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE FORMATION; BONE MARROW STROMAL CELLS; BONE REGENERATION; CELL PRODUCTS; CELL SOURCES; CERAMIC SCAFFOLDS; CLINICAL TRIAL; GOOD MANUFACTURING PROCESS; HUMAN PATIENTS; OSTEOGENIC; PLURIPOTENT STEM CELLS; SCALE-UP;

BONE; EXPERIMENTS; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

TISSUE SCAFFOLD;

BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; CELL DIFFERENTIATION; CELL TYPE; CERAMICS; GOOD MANUFACTURING PRACTICE; HUMAN; NONHUMAN; OSSIFICATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SCALE UP; STROMA CELL;

BONE MARROW CELLS; BONE REGENERATION; CELL SEPARATION; CELL TRANSPLANTATION; HUMANS; STROMAL CELLS;

EID: 81755166878     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2011.0199     Document Type: Review

References (56)

1. Friedenstein, A.J., Piatetzky-Shapiro, I.I., and Petrakova, K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16, 381, 1966.
2. Bianco, P., Riminucci, M., Gronthos, S., and Robey, P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19, 180, 2001.
3. Friedenstein, A.J., Chailakhyan, R.K., and Gerasimov, U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20, 263, 1987.
4. Friedenstein, A.J., Chailakhyan, R.K., Latsinik, N.V., Panasyuk, A.F., and Keiliss-Borok, I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331, 1974.
5. Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., Emmons, R.V., Rowe, D.W., and Robey, P.G. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63, 1059, 1997.
6. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
7. Bianco, P., Robey, P.G., and Simmons, P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313, 2008.
8. Caplan, A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11, 1198, 2005.
9. Hicok, K.C., Du Laney, T.V., Zhou, Y.S., Halvorsen, Y.D., Hitt, D.C., Cooper, L.F., et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 10, 371, 2004.
10. Gronthos, S., Mankani, M., Brahim, J., Robey, P.G., and Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97, 13625, 2000.
11. Miura, M., Gronthos, S., Zhao, M., Lu, B., Fisher, L.W., Robey, P.G., et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100, 5807, 2003.
12. Kharlamova, L.A. [Colony formation inhibition in human bone marrow stromal cells exposed to a factor formed in vitro by peripheral blood leukocytes]. Biull Eksp Biol Med 80, 89, 1975.
13. Bianco, P., Kuznetsov, S.A., Riminucci, M., and Gehron Robey, P. Postnatal skeletal stem cells. Methods Enzymol 419, 117, 2006.
14. Howard, G.A., Turner, R.T., Sherrard, D.J., and Baylink, D.J. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3. J Biol Chem 256, 7738, 1981.
15. Beresford, J.N., Gallagher, J.A., Poser, J.W., and Russell, R.G. Production of osteocalcin by human bone cells in vitro. Effects of 1, 25(OH)2D3, 24, 25(OH)2D3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Relat Res 5, 229, 1984.
16. Robey, P.G., and Termine, J.D. Human bone cells in vitro. Calcif Tissue Int 37, 453, 1985.
17. Nakahara, H., Goldberg, V.M., and Caplan, A.I. Cultureexpanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9, 465, 1991.
18. O'Driscoll, S.W., Recklies, A.D., and Poole, A.R. Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg Am 76, 1042, 1994.
19. Kuznetsov, S.A., Mankani, M.H., Gronthos, S., Satomura, K., Bianco, P., and Robey, P.G. Circulating skeletal stem cells. J Cell Biol 153, 1133, 2001.
20. Kuznetsov, S.A., Mankani, M.H., Leet, A.I., Ziran, N., Gronthos, S., and Robey, P.G. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells 25, 1830, 2007.
21. Friedenstein, A.J. Precursor cells of mechanocytes. Int Rev Cytol 47, 327, 1976.
22. Kuznetsov, S.A., Mankani, M.H., Bianco, P., and Robey, P.G. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res 2, 83, 2009.
23. Dexter, T.M., Allen, T.D., and Lajtha, L.G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91, 335, 1977.
24. Bonewald, L.F., Harris, S.E., Rosser, J., Dallas, M.R., Dallas, S.L., Camacho, N.P., et al. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 72, 537, 2003.
25. Kuznetsov, S.A., Krebsbach, P.H., Satomura, K., Kerr, J., Riminucci, M., Benayahu, D., et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12, 1335, 1997.
26. Liechty, K.W., MacKenzie, T.C., Shaaban, A.F., Radu, A., Moseley, A.M., Deans, R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6, 1282, 2000.
27. Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S., and Galipeau, J. Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 106, 4057, 2005.
28. Olsen, B.R., Reginato, A.M., and Wang, W. Bone development. Annu Rev Cell Dev Biol 16, 191, 2000.
29. Akintoye, S.O., Lam, T., Shi, S., Brahim, J., Collins, M.T., and Robey, P.G. Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 38, 758, 2006.
30. Burnette, E.W., Jr. Fate of an iliac crest graft. J Periodontol 43, 88, 1972.
31. Peister, A., Deutsch, E.R., Kolambkar, Y., Hutmacher, D.W., and Guldberg, R.E. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A 15, 3129, 2009.
32. Erices, A., Conget, P., and Minguell, J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109, 235, 2000.
33. Sonoyama, W., Liu, Y., Fang, D., Yamaza, T., Seo, B.M., Zhang, C., et al. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One 1, e79, 2006.
34. Boyde, A., and Jones, S.J. Development and structure of teeth and periodontal tissues. In: Rosen, C.J., ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 7th edition. Washington, D.C.: American Society for Bone and Mineral Research, 2008, pp. 491-496.
35. Porada, C.D., Zanjani, E.D., and Almeida-Porad, G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 1, 365, 2006.
36. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145, 1998.
37. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861, 2007.
38. Zhou, H., and Ding, S. Evolution of induced pluripotent stem cell technology. Curr Opin Hematol 17, 276, 2010.
39. Illich, D.J., Demir, N., Stojkovic, M., Scheer, M., Rothamel, D., Neugebauer, J., et al. Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration. Stem Cells 29, 555, 2011.
40. Tashiro, K., Inamura, M., Kawabata, K., Sakurai, F., Yamanishi, K., Hayakawa, T., et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27, 1802, 2009.
41. Li, F., Bronson, S., and Niyibizi, C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 109, 643, 2010.
42. Bilousova, G., Hyun Jun, D., King, K.B., Delanghe, S., Chick, W.S., Torchia, E.C., et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vitro. Stem Cells 29, 206, 2011.
43. Lian, Q., Zhang, Y., Zhang, J., Zhang, H.K., Wu, X., Lam, F.F., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113, 2010.
44. Arpornmaeklong, P., Brown, S.E., Wang, Z., and Krebsbach, P.H. Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev 18, 955, 2009.
45. Kuznetsov, S.A., Cherman, N., and Robey, P.G. In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev 20, 269, 2011.
46. Hernigou, P., Poignard, A., Manicom, O., Mathieu, G., and Rouard, H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 87, 896, 2005.
47. Piersanti, S., Remoli, C., Saggio, I., Funari, A., Michienzi, S., Sacchetti, B., et al. Transfer, analysis and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res 25, 1103, 2010.
48. Chatterjea, A., Meijer, G., van Blitterswijk, C., and de Boer, J. Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int 2010, 215625, 2010.
49. Oh, S., Oh, N., Appleford, M., and Ong, J.L. Bioceramics for tissue engineering applications-a review. Am J Biochem Biotechnol 2, 49, 2006.
50. Rezwan, K., Chen, Q.Z., Blaker, J.J., and Boccaccini, A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27, 3413, 2006.
51. Kretlow, J.D., and Mikos, A.G. Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng 13, 927, 2007.
52. Mankani, M.H., Kuznetsov, S.A., Marshall, G.W., and Robey, P.G. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14, 1949, 2008.
53. Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M.P., Robbins, R.C., and Pelletier, M.P. Stem cell transplantation: the lung barrier. Transplant Proc 39, 573, 2007.
54. Sackstein, R., Merzaban, J.S., Cain, D.W., Dagia, N.M., Spencer, J.A., Lin, C.P., et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14, 181, 2008.
55. Nauta, A.J., and Fibbe, W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499, 2007.
56. Nemeth, K., Leelahavanichkul, A., Yuen, P.S., Mayer, B., Parmelee, A., Doi, K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42, 2009.